173 related articles for article (PubMed ID: 35064580)
41. Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling.
Keller CD; Rivera Gil P; Tölle M; van der Giet M; Chun J; Radeke HH; Schäfer-Korting M; Kleuser B
Am J Pathol; 2007 Jan; 170(1):281-92. PubMed ID: 17200201
[TBL] [Abstract][Full Text] [Related]
42. FTY720 protects cardiac microvessels of diabetes: a critical role of S1P1/3 in diabetic heart disease.
Yin Z; Fan L; Wei L; Gao H; Zhang R; Tao L; Cao F; Wang H
PLoS One; 2012; 7(8):e42900. PubMed ID: 22916176
[TBL] [Abstract][Full Text] [Related]
43. The sphingosine-1-phosphate analog FTY720 reduces muscle ceramide content and improves glucose tolerance in high fat-fed male mice.
Bruce CR; Risis S; Babb JR; Yang C; Lee-Young RS; Henstridge DC; Febbraio MA
Endocrinology; 2013 Jan; 154(1):65-76. PubMed ID: 23183172
[TBL] [Abstract][Full Text] [Related]
44. A novel immunosuppressant, FTY720, induces peripheral lymphodepletion of both T- and B cells and immunosuppression in baboons.
Quesniaux V; Fullard L; Arendse H; Davison G; Markgraaff N; Auer R; Ehrhart F; Kraus G; Schuurman HJ
Transpl Immunol; 1999 Sep; 7(3):149-57. PubMed ID: 10608298
[TBL] [Abstract][Full Text] [Related]
45. Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis.
Coldewey SM; Benetti E; Collino M; Pfeilschifter J; Sponholz C; Bauer M; Huwiler A; Thiemermann C
Sci Rep; 2016 Jun; 6():27594. PubMed ID: 27277195
[TBL] [Abstract][Full Text] [Related]
46. Lymphocyte modulation with FTY720 improves hemorrhagic shock survival in swine.
Hawksworth JS; Graybill JC; Brown TS; Wallace SM; Davis TA; Tadaki DK; Elster EA
PLoS One; 2012; 7(4):e34224. PubMed ID: 22558085
[TBL] [Abstract][Full Text] [Related]
47. [Cross-sectional study of the pathophysiologic and clinical features in the first-degree relatives of type 2 diabetic patients].
Han XY; Ji LN; Zhou XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):159-62. PubMed ID: 15841145
[TBL] [Abstract][Full Text] [Related]
48. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
49. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
Kihara A; Igarashi Y
Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
[TBL] [Abstract][Full Text] [Related]
50. The experimental research of pregnancy immune tolerance induced by FTY720 via blocking S1P signal transduction pathway.
Xiong M; Xu L; Li L; Liu Y; Zhou F; Wang J; Zhu J
J Cell Biochem; 2019 Apr; 120(4):5897-5905. PubMed ID: 30362168
[TBL] [Abstract][Full Text] [Related]
51. [New therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
Chiba K
Yakugaku Zasshi; 2009 Jun; 129(6):655-65. PubMed ID: 19483408
[TBL] [Abstract][Full Text] [Related]
52. Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice.
Xiong WT; Gu L; Wang C; Sun HX; Liu X
J Ethnopharmacol; 2013 Dec; 150(3):935-45. PubMed ID: 24095831
[TBL] [Abstract][Full Text] [Related]
53. [The effect of liraglutide in combination with human umbilical cord mesenchymal stem cells treatment on glucose metabolism and β cell function in type 2 diabetes mellitus].
Chen P; Huang Q; Xu XJ; Shao ZL; Huang LH; Yang XZ; Guo W; Li CM; Chen C
Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):349-54. PubMed ID: 27143183
[TBL] [Abstract][Full Text] [Related]
54. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
[TBL] [Abstract][Full Text] [Related]
55. Diabetic Retinopathy in Newly Diagnosed Subjects With Type 2 Diabetes Mellitus: Contribution of β-Cell Function.
Roy Chowdhury S; Thomas RL; Dunseath GJ; Peter R; Rees DA; North RV; Luzio SD; Owens DR
J Clin Endocrinol Metab; 2016 Feb; 101(2):572-80. PubMed ID: 26652932
[TBL] [Abstract][Full Text] [Related]
56. FTY720/fingolimod, an oral S1PR modulator, mitigates radiation induced cognitive deficits.
Stessin AM; Banu MA; Clausi MG; Berry N; Boockvar JA; Ryu S
Neurosci Lett; 2017 Sep; 658():1-5. PubMed ID: 28822836
[TBL] [Abstract][Full Text] [Related]
57. The sphingosine 1-phosphate receptor modulator FTY720 prevents iodide-induced autoimmune thyroiditis in non-obese diabetic mice.
Morohoshi K; Osone M; Yoshida K; Nakagawa Y; Hoshikawa S; Ozaki H; Takahashi Y; Ito S; Mori K
Autoimmunity; 2011 Sep; 44(6):490-5. PubMed ID: 21457062
[TBL] [Abstract][Full Text] [Related]
58. Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720.
Maki T; Gottschalk R; Ogawa N; Monaco AP
Transplantation; 2005 May; 79(9):1051-5. PubMed ID: 15880042
[TBL] [Abstract][Full Text] [Related]
59. The usefulness of the estimated average glucose/fasting blood glucose ratio for pancreatic β-cell function assessment in hyperglycemia during health checkups.
Nah EH; Cho S; Park H; Kim S; Kwon E; Cho HI
J Clin Lab Anal; 2022 Oct; 36(10):e24693. PubMed ID: 36098986
[TBL] [Abstract][Full Text] [Related]
60. Butanol fraction of Parkia biglobosa (Jacq.) G. Don leaves enhance pancreatic β-cell functions, stimulates insulin secretion and ameliorates other type 2 diabetes-associated complications in rats.
Ibrahim MA; Habila JD; Koorbanally NA; Islam MS
J Ethnopharmacol; 2016 May; 183():103-111. PubMed ID: 26911526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
